1. An introduction to psychedelic neuroscienceTanya Calvey and Fleur M. Howells2. The renaissance in psychedelic research: What do preclinical models have to offerKevin S. Murnane3. D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disordersDanilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi4. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decompositionSelen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach5. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorderJoseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey6. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brainFelix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt7. Neurocognitive effects of cannabis: Lessons learned from human experimental studiesMarco Colizzi and Sagnik Bhattacharyya8. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangersJohn Martin Corkery
